Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CLARINEX-D® 12 HOUR Extended Release Tablets safely and effectively. See full prescribing information for CLARINEX-D 12 HOUR Extended Release Tablets. CLARINEX-D 12 HOUR Extended Release Tablets (desloratadine/pseudoephedrine sulfate) for oral use. Initial U.S. Approval: 2005
Medication labelWhy this: Advisory · dailymed-prescription
CLARINEX-D® 12 HOUR Extended Release Tablets is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis, including nasal congestion, in adults and adolescents 12 years of age and older. CLARINEX-D 12 HOUR Extended Release Tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired [see Clinical Pharmacology (12)].
- generic_name
- desloratadine and pseudoephedrine sulfate
- product_names
- desloratadine and pseudoephedrine sulfate
- ndc
- 54868-5708, 0085-1322, 54868-5708-0, 54868-5708-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en